• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Increased p53 activity does not accelerate telomere-driven ageing.p53活性增加不会加速端粒驱动的衰老。
EMBO Rep. 2006 May;7(5):546-52. doi: 10.1038/sj.embor.7400667. Epub 2006 Mar 31.
2
[Aging or tumor: the crosstalk between telomerase and p53].衰老还是肿瘤:端粒酶与p53之间的相互作用
Yi Chuan. 2009 May;31(5):451-6. doi: 10.3724/sp.j.1005.2009.00451.
3
Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing.端粒功能障碍和Atm缺陷会损害器官内环境稳定并加速衰老。
Nature. 2003 Feb 6;421(6923):643-8. doi: 10.1038/nature01385. Epub 2003 Jan 22.
4
Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.端粒下游p53对细胞衰老、组织功能及癌症的调控
Cold Spring Harb Perspect Med. 2017 May 1;7(5):a026088. doi: 10.1101/cshperspect.a026088.
5
Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation.端粒酶缺失和端粒缩短导致心脏扩张和心力衰竭,并伴有p53上调。
EMBO J. 2003 Jan 2;22(1):131-9. doi: 10.1093/emboj/cdg013.
6
Telomere shortening in neural stem cells disrupts neuronal differentiation and neuritogenesis.神经干细胞中的端粒缩短会破坏神经元分化和神经突形成。
J Neurosci. 2009 Nov 18;29(46):14394-407. doi: 10.1523/JNEUROSCI.3836-09.2009.
7
Dietary restriction ameliorates haematopoietic ageing independent of telomerase, whilst lack of telomerase and short telomeres exacerbates the ageing phenotype.饮食限制可改善造血衰老,且与端粒酶无关,而缺乏端粒酶和短端粒会加剧衰老表型。
Exp Gerontol. 2014 Oct;58:113-9. doi: 10.1016/j.exger.2014.07.010. Epub 2014 Jul 17.
8
Immunosenescence phenotypes in the telomerase knockout mouse.端粒酶基因敲除小鼠的免疫衰老表型
Springer Semin Immunopathol. 2002;24(1):75-85. doi: 10.1007/s00281-001-0096-1.
9
Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.Ink4a/Arf肿瘤抑制因子不会调节端粒酶缺陷型小鼠的退行性疾病或肿瘤谱。
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3931-6. doi: 10.1073/pnas.0700093104. Epub 2007 Feb 27.
10
p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.p53基因缺失可挽救端粒缺失的不良影响,并与端粒功能障碍协同作用以加速肿瘤发生。
Cell. 1999 May 14;97(4):527-38. doi: 10.1016/s0092-8674(00)80762-x.

引用本文的文献

1
37 kDa LRP::FLAG enhances telomerase activity and reduces ageing markers in vivo.37千道尔顿的低密度脂蛋白受体相关蛋白(LRP)::FLAG在体内增强端粒酶活性并减少衰老标志物。
Cell Mol Life Sci. 2025 Feb 22;82(1):83. doi: 10.1007/s00018-025-05593-0.
2
The Pivotal Role of One-Carbon Metabolism in Neoplastic Progression During the Aging Process.一碳代谢在衰老过程中肿瘤进展中的关键作用。
Biomolecules. 2024 Oct 31;14(11):1387. doi: 10.3390/biom14111387.
3
Traditional herbs: mechanisms to combat cellular senescence.传统草药:对抗细胞衰老的机制。
Aging (Albany NY). 2023 Dec 5;15(23):14473-14505. doi: 10.18632/aging.205269.
4
Impaired telomere pathway and fertility in Senescence-Accelerated Mice Prone 8 females with reproductive senescence.生殖衰老加速敏感 8 号雌性小鼠端粒通路和生育能力受损。
Aging (Albany NY). 2023 May 23;15(11):4600-4624. doi: 10.18632/aging.204731.
5
Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy.针对 USP2 调节 VPRBP 介导的 p53 和 PD-L1 降解以用于癌症治疗。
Nat Commun. 2023 Apr 6;14(1):1941. doi: 10.1038/s41467-023-37617-3.
6
Breaking the aging epigenetic barrier.打破衰老的表观遗传屏障。
Front Cell Dev Biol. 2022 Jul 28;10:943519. doi: 10.3389/fcell.2022.943519. eCollection 2022.
7
The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis.器官发育和稳态中的衰老标志物 p16INK4A、p14ARF/p19ARF 和 p21。
Cells. 2022 Jun 19;11(12):1966. doi: 10.3390/cells11121966.
8
Cancer and Aging: Two Tightly Interconnected Biological Processes.癌症与衰老:两个紧密相连的生物学过程。
Cancers (Basel). 2021 Mar 19;13(6):1400. doi: 10.3390/cancers13061400.
9
AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer.AAV9 介导的端粒酶激活在致癌 K-Ras 诱导的肺癌背景下不会加速肿瘤发生。
PLoS Genet. 2018 Aug 16;14(8):e1007562. doi: 10.1371/journal.pgen.1007562. eCollection 2018 Aug.
10
Jun dimerization protein 2 controls hypoxia-induced replicative senescence via both the p16-pRb and Arf-p53 pathways.Jun二聚化蛋白2通过p16-pRb和Arf-p53途径控制缺氧诱导的复制性衰老。
FEBS Open Bio. 2017 Oct 16;7(11):1793-1804. doi: 10.1002/2211-5463.12325. eCollection 2017 Nov.

本文引用的文献

1
Tumor suppression and normal aging in mice with constitutively high p53 activity.p53活性持续升高的小鼠中的肿瘤抑制与正常衰老
Genes Dev. 2006 Jan 1;20(1):16-21. doi: 10.1101/gad.1378506.
2
Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.Ink4a/Arf基因剂量增加可导致抗癌能力和正常衰老。
Genes Dev. 2004 Nov 15;18(22):2736-46. doi: 10.1101/gad.310304. Epub 2004 Nov 1.
3
Phosphorylation of H2AX at short telomeres in T cells and fibroblasts.T细胞和成纤维细胞中短端粒处H2AX的磷酸化。
J Biol Chem. 2004 Oct 22;279(43):45148-54. doi: 10.1074/jbc.M403924200. Epub 2004 Aug 17.
4
Long lifespan in worms with long telomeric DNA.端粒DNA长的蠕虫寿命长。
Nat Genet. 2004 Jun;36(6):607-11. doi: 10.1038/ng1356. Epub 2004 May 2.
5
Modulation of mammalian life span by the short isoform of p53.p53短异构体对哺乳动物寿命的调控
Genes Dev. 2004 Feb 1;18(3):306-19. doi: 10.1101/gad.1162404.
6
Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks.衰老的人类细胞和老化的小鼠会积累带有无法修复的双链断裂的DNA损伤。
Nat Cell Biol. 2004 Feb;6(2):168-70. doi: 10.1038/ncb1095.
7
Telomeres, stem cells, senescence, and cancer.端粒、干细胞、衰老与癌症。
J Clin Invest. 2004 Jan;113(2):160-8. doi: 10.1172/JCI20761.
8
Replicative senescence and the art of counting.复制性衰老与计数的技巧。
Exp Gerontol. 2003 Nov-Dec;38(11-12):1259-64. doi: 10.1016/j.exger.2003.09.015.
9
A DNA damage checkpoint response in telomere-initiated senescence.端粒引发的衰老中的DNA损伤检查点反应。
Nature. 2003 Nov 13;426(6963):194-8. doi: 10.1038/nature02118. Epub 2003 Nov 5.
10
DNA damage foci at dysfunctional telomeres.功能失调的端粒处的DNA损伤灶。
Curr Biol. 2003 Sep 2;13(17):1549-56. doi: 10.1016/s0960-9822(03)00542-6.

p53活性增加不会加速端粒驱动的衰老。

Increased p53 activity does not accelerate telomere-driven ageing.

作者信息

García-Cao Isabel, García-Cao Marta, Tomás-Loba Antonia, Martín-Caballero Juan, Flores Juana M, Klatt Peter, Blasco María A, Serrano Manuel

机构信息

Tumor Suppression Group, Spanish National Cancer Center, Madrid.

出版信息

EMBO Rep. 2006 May;7(5):546-52. doi: 10.1038/sj.embor.7400667. Epub 2006 Mar 31.

DOI:10.1038/sj.embor.7400667
PMID:16582880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1479549/
Abstract

There is a great interest in determining the impact of p53 on ageing and, for this, it is important to discriminate among the known causes of ageing. Telomere loss is a well-established source of age-associated damage, which by itself can recapitulate ageing in mouse models. Here, we have used a genetic approach to interrogate whether p53 contributes to the elimination of telomere-damaged cells and its impact on telomere-driven ageing. We have generated compound mice carrying three functional copies of the p53 gene (super-p53) in a telomerase-deficient background and we have measured the presence of chromosomal abnormalities and DNA damage in several tissues. We have found that the in vivo load of telomere-derived chromosomal damage is significantly decreased in super-p53/telomerase-null mice compared with normal-p53/telomerase-null mice. Interestingly, the presence of extra p53 activity neither accelerates nor delays telomere-driven ageing. From these observations, we conclude that p53 has an active role in eliminating telomere-damaged cells, and we exclude the possibility of an age-promoting effect of p53 on telomere-driven ageing.

摘要

人们对确定p53对衰老的影响有着浓厚兴趣,为此,区分已知的衰老原因很重要。端粒损耗是与年龄相关损伤的一个公认来源,其本身就能在小鼠模型中重现衰老过程。在此,我们采用遗传学方法来探究p53是否有助于清除端粒受损细胞及其对端粒驱动衰老的影响。我们构建了在端粒酶缺陷背景下携带三个p53基因功能拷贝(超级p53)的复合小鼠,并检测了多个组织中染色体异常和DNA损伤的情况。我们发现,与正常p53/端粒酶缺失小鼠相比,超级p53/端粒酶缺失小鼠中端粒衍生的染色体损伤的体内负荷显著降低。有趣的是,额外的p53活性既不加速也不延迟端粒驱动的衰老。基于这些观察结果,我们得出结论,p53在清除端粒受损细胞中发挥着积极作用,并且我们排除了p53对端粒驱动衰老具有促进衰老作用的可能性。